HUMAN GENE TRANSFER/THERAPY PROTOCOL 
9105-007 
Deisseroth, Albert B., M.D. Anderson Cancer Center; Autologous Bone 
Marrow Transplantation for Chronic Myelogenous Leukemia in which 
Retroviral Markers are Used to Discriminate between Relapse which Arises 
from Systemic Disease Remaining after Preparative Therapy Versus 
Relapse due to Residual Leukemic Cells in Autologous Marrow: A Pilot 
Trial. 
Date of RAC Approval: 5/31/91 
Date of NIH Approval: 
[740] 
Recombinant DNA Research, Volume 14 
